Back

Progression of myocardial fibrosis is the major determinant of heart failure hospitalization in patients undergoing transcatheter aortic valve implantation.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Unresolved questions in TAVI: stroke protection and left ventricular structure and function Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Kenta Yamaguchi

National Cerebral & Cardiovascular Center, Suita (Japan)

8 More presentations in this session

Presentation thumbnail
Identification of new instances of white matter hyperintensities in patients following TAVI (from the CAPITA study)
Doctor K. Hemelrijk (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Predisposing and precipitating factors of post-operative delirium after transfemoral TAVI
Doctor K. Steinhaus (Goettingen, DE)
Abstract Slides Video
Presentation thumbnail
Objective functional improvement and vital prognosis after TAVR in patients with low-gradient aortic stenosis. Development of a predictive score.
Doctor C. Garilleti Camara (Santander, ES)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of left ventricular ejection fraction improvement after transcatheter aortic valve replacement
Mr J. Reichl (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Echocardiographic and clinical features of patients developing prosthesis-patient mismatch after TAVI: insights from an international multicenter registry.
Doctor J. Rampone (Turin, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Unresolved questions in TAVI: stroke protection and left ventricular structure and function

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The independent factors associated with myocardial extracellular volume fraction in acute decompensated heart failure patients
thumbnail
Congress Presentation
Elevated preprocedural CT-ECV predicts residual LV morphological and functional impairment after TAVI
thumbnail
Congress Presentation
Myocardial interstitial fibrosis as a prognostic factor for right ventricular failure post left ventricular assist device implantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources